Drug Safety Reform List of articles

ELIQUENT Japan > Drug Safety Reform

2025.05.29

Drug,prescription,for,treatment,medication.,pharmaceutical,medicament,,cure,in,container

Key Amendments to the PMD Act — Strengthening Conditional Approval and Post-Market Safety

Introduction to Legislative ProgressAccording to news (薬機法等改正法案　参院厚労委で賛成多数で可決　15項目の附帯決議採択　14日にも成立へ | ニュース | ミク […]

COMPANY

Company Name: Eliquent Japan, Inc.
Location: Shinjuku i-Land Tower 41F, 6-5-1 Nishi Shinjuku, Shinjuku-ku 163-1341 Tokyo, Japan
Representative Director, CEO: Shunsuke Iwano
Business Scope: Regulatory Consulting
 Phone:+81-3-6304-5570